Luis Fernando Mayorga

Dr. Luis Fernando Mayorga

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
RMRasika Ann Mathias
Rasika Ann Mathias
MTMargaret A. Taub
Margaret A. Taub
CGChristopher R. Gignoux
Christopher R. Gignoux
WFWenqing Fu
Wenqing Fu
SMShaila Musharoff
Shaila Musharoff
KBKathleen C. Barnes
Kathleen C. Barnes
The African Diaspora in the Western Hemisphere represents one of the largest forced migrations in history and had a profound impact on genetic diversity in modern populations. To date, the fine-scale population structure of descendants of the African Diaspora remains largely uncharacterized. Here we present genetic variation from deeply sequenced genomes of 642 individuals from North and South American, Caribbean and West African populations, substantially increasing the lexicon of human genomic variation and suggesting much variation remains to be discovered in African-admixed populations in the Americas. We summarize genetic variation in these populations, quantifying the postcolonial sex-biased European gene flow across multiple regions. Moreover, we refine estimates on the burden of deleterious variants carried across populations and how this varies with African ancestry. Our data are an important resource for empowering disease mapping studies in African-admixed individuals and will facilitate gene discovery for diseases disproportionately affecting individuals of African ancestry.

2 December 2021 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
GSGerard Serrano-Gómez
Gerard Serrano-Gómez
LMLuis Fernando Mayorga
Luis Fernando Mayorga
IOIñigo Oyarzun
Iñigo Oyarzun
JRJoaquim Roca
Joaquim Roca
NBNatalia Borruel
Natalia Borruel
CMChaysavanh Manichanh
Chaysavanh Manichanh
• CD more dysbiotic than UC both at the microbial taxonomic and functional level. • E. coli enriched in CD and almost undetected in UC. • Production of propionate driven by E. coli in CD and by Anaerostipes hadrus in UC and healthy controls. • Microbial signatures and random forest enabled discrimination of IBD vs. non-IBD and prediction of flare.

17 April 2023 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
CGClaudia Herrera-de Guise
Claudia Herrera-de Guise
EVEncarna Varela
Encarna Varela
GSGuillaume Sarrabayrouse
Guillaume Sarrabayrouse
MRMarta Pozuelo del Río
Marta Pozuelo del Río
VAVirginia Robles Alonso
Virginia Robles Alonso
FGFrancisco Guarner
Francisco Guarner
Background: Microbiome studies report low gut microbial richness and diversity in ulcerative colitis (UC) patients. We explored whether UC patients who reach long-term clinical, endoscopic, and histological remission show a gut microbial ecosystem that is similar to healthy individuals. Methods: We collected 184 stool samples from 111 individuals (UC patients in long remission, short remission, flare, and healthy control subjects). Microbiota was analyzed by amplicon sequencing (16S ribosomal RNA) and quantitative polymerase chain reaction for specific taxa. All UC remission patients were followed-up for 2 years. Findings: A drop in species diversity and richness, underrepresentation of butyrate producers, and gain of potentially harmful bacteria were significantly detected in samples from disease-flare and short-remission patients. In contrast, Chao1 and Shannon indexes of diversity did not differ among patients in long remission and healthy control subjects. Long-remission patients also presented fecal bacterial composition closer to that in healthy control subjects. There was a positive correlation between Akkermansia muciniphila abundance and time in remission (rs = 0.53, P < .001). Logistic regression analysis showed that a high Shannon index (odds ratio, 4.83; 95% confidence interval, 1.5-20.6) or presence of A. muciniphila (odds ratio, 4.9; 95% confidence interval, 1.12-29.08) in fecal samples at entry was independently associated with clinical remission over a follow-up period of 24 months. Interpretation: UC patients who achieve long-term remission show evidence of substantial recovery of the gut microbial ecosystem in terms of diversity and composition. Recovery may just reflect adequate control of inflammatory activity, but higher bacterial diversity or the presence of A. muciniphila in fecal samples predicts flare-free outcomes.

27 April 2021 in mSystems
Verified
Journal Article
Open access
PDF file
GSG. Sarrabayrouse
G. Sarrabayrouse
AEA. Elias
A. Elias
FYF. Yáñez
F. Yáñez
LMLuis Fernando Mayorga
Luis Fernando Mayorga
EVE. Varela
E. Varela
CMChaysavanh Manichanh
Chaysavanh Manichanh
Next-generation sequence data analysis has allowed a better understanding of the pathophysiology of IBD, relating microbiome composition and functions to the disease. Microbiome composition profiling may provide efficient diagnosis and prognosis tools in IBD.

6 January 2026 in Gut
Verified
Journal Article
Open access
LMLuis Fernando Mayorga
Luis Fernando Mayorga
ASArnau Noguera Segura
Arnau Noguera Segura
LCLaura Campderros
Laura Campderros
MPMarc Pons-Tarin
Marc Pons-Tarin
Zaida LuqueZaida Luque
Zaida Luque
CMChaysavanh Manichanh
Chaysavanh Manichanh
Background: Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways involved, and their differences between Crohn’s disease (CD) and ulcerative colitis (UC), the two main subtypes of IBD remain unclear. Objective: To investigate how the gut microbiome mediates the effects of habitual diet on inflammatory activity in IBD. Design: This longitudinal study included 198 adults (100 healthy controls, 49 CD, 49 UC), participants completed a validated food frequency questionnaire. Dietary quality was evaluated using established indices (Alternative Mediterranean Diet, Healthy Eating Index-2015, Índice de Alimentación Saludable, Mean Adequacy Ratio, Plant-Based Dietary Indexes, Healthy Food Diversity). Participants also provided two stool samples (baseline and 6 months). Shotgun metagenomics (n=366) enabled taxonomic and functional profiling. Causal mediation analyses were used to identify microbial features mediating the effect of diet on inflammation. Results: IBD patients exhibited lower dietary diversity, fibre intake and nutritional adequacy compared with controls. Microbiome diversity was lowest in CD, intermediate in UC and correlated positively with higher intake of fibre, fruit, vegetables and nuts, and negative with processed foods and sugary beverages. Causal mediation analyses revealed that in CD, coffee, whole wheat bread and healthier diets lowered the Harvey-Bradshaw index through specific bacterial species and metabolites. In UC, Mediterranean-like diets, fruits and coffee reduced C reactive protein via greater microbial richness, reduced dysbiosis and short-chain fatty acid-related functions. Conclusion: Diet quality influences inflammation in IBD through distinct microbiome pathways: specific taxa and metabolites mediate effects in CD, whereas microbial richness and global composition drive protection in UC.

16 June 2025 in Biomarker Research
Verified
Journal Article
Open access
PDF file
GSGerard Serrano-Gómez
Gerard Serrano-Gómez
FYFrancisca Yañez
Francisca Yañez
ZSZaida Soler
Zaida Soler
MPMarc Pons-Tarin
Marc Pons-Tarin
LMLuis Fernando Mayorga
Luis Fernando Mayorga
CMChaysavanh Manichanh
Chaysavanh Manichanh
Background: The gut microbiome plays a key role in the development of inflammatory bowel disease (IBD), as imbalances in microbial composition are associated with immune dysfunction. However, the specific mechanisms by which certain microorganisms contribute to this process remain unclear. Methods: Here, we employed a multi-omics approach on fecal samples to identify novel microbiome markers and elucidate mechanisms underlying IBD. Shotgun metagenomics was applied to 212 samples (850 in total with validation cohort), shotgun metatranscriptomics to 103 samples and metabolomics to 105 samples. Machine learning techniques were used to predict disease and the three omics data were integrated to propose a mechanistic role of the microbiota. Results: Metagenomic analysis identified Crohn's disease (CD)-specific microbiome signatures, including a panel of 20 species that achieved a high diagnostic performance, with an area under the ROC curve (AUC) of 0.94 in an external validation set. Metatranscriptomic analysis revealed significant alterations in microbial fermentation pathways in CD, but not in ulcerative colitis (UC), highlighting disruptions that explain the depletion of butyrate—a key anti-inflammatory metabolite—observed in metabolomics analysis. Integrative multi-omics analyses further identified active virulence factor genes in CD, predominantly originating from the adherent-invasive Escherichia coli (AIEC). Notably, these findings unveiled novel mechanisms, including E. coli-mediated aspartate depletion and the utilization of propionate, which drives the expression of the ompA virulence gene, critical for bacterial adherence and invasion of the host’s macrophages. Interestingly, these microbiome alterations were absent in UC, underscoring distinct mechanisms of disease development between the two IBD subtypes. Conclusions: In conclusion, our study not only identifies promising novel biomarkers with strong diagnostic potential, which could be valuable in challenging clinical scenarios, but also offers an integrated multi-omics perspective on the microbial mechanisms underlying inflammation and virulence in Crohn's disease.